These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4044046)

  • 21. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
    Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
    Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal studies on the reduction of aminoglycoside-induced nephrotoxicity by D-glucaro-1,5-lactam.
    Marre R; Müller W; Sack K
    Infection; 1983; 11(3):155-60. PubMed ID: 6885175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin.
    Yano Y; Hiraoka A; Oguma T
    J Pharmacol Exp Ther; 1995 Aug; 274(2):695-9. PubMed ID: 7636730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fosfomycin protects against tubulotoxicity induced by cis-diaminedichloroplatin and cyclosporin A in the rat.
    Sack K; Schulz E; Marre R; Kreft B
    Klin Wochenschr; 1987 Jun; 65(11):525-7. PubMed ID: 3613466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin.
    Kacew S; Hewitt WR; Hook JB
    Toxicol Appl Pharmacol; 1989 Jun; 99(1):61-71. PubMed ID: 2524910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative animal studies on the potential nephrotoxicity of new cephalosporins: EMD 29 645, EMD 29 946, cefuroxine and cefamandole].
    Sack K; Nierhoff N; Züllich B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1597-9. PubMed ID: 611886
    [No Abstract]   [Full Text] [Related]  

  • 27. Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice.
    Takigawa M; Masutomi H; Kishimoto Y; Shimazaki Y; Hamano Y; Kondo Y; Arai T; Lee J; Ishii T; Mori Y; Ishigami A
    Biol Pharm Bull; 2017; 40(7):975-983. PubMed ID: 28674262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotoxicity of gentamicin and vancomycin given alone and in combination as determined by enzymuria and cortical antibiotic levels in rats.
    Fauconneau B; Favrelière S; Pariat C; Génévrier A; Courtois P; Piriou A; Bouquet S
    Ren Fail; 1997 Jan; 19(1):15-22. PubMed ID: 9044448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental study in rats on the renal compatibility of cephalothin and cephalothin-aminoglycoside combinations (author's transl)].
    Wilhelm J; Sack K
    Infection; 1975; 3(2):89-95. PubMed ID: 1184195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity.
    Celik I; Cihangiroglu M; Ilhan N; Akpolat N; Akbulut HH
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):325-32. PubMed ID: 16236146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can fosfomycin reduce the nephrotoxicity of aminoglycosides?].
    Morin JP; Olier B; Viotte G; Fillastre JP
    Pathol Biol (Paris); 1984 May; 32(5):338-42. PubMed ID: 6739142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
    Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
    J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aminoglycosides on glomerular permeability, tubular reabsorption, and intracellular catabolism of the cationic low-molecular-weight protein lysozyme.
    Cojocel C; Dociu N; Maita K; Sleight SD; Hook JB
    Toxicol Appl Pharmacol; 1983 Mar; 68(1):96-109. PubMed ID: 6845378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal brush border membrane vesicle aminoglycoside binding and nephrotoxicity.
    Todd JH; Hottendorf GH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):258-63. PubMed ID: 7616406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of netilmicin and other aminoglycosides on renal function. A survey of the literature on the nephrotoxicity of netilmicin.
    Dahlager JI
    Scand J Infect Dis Suppl; 1980; Suppl 23():96-102. PubMed ID: 7010549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymuria: a parameter for the assessment of potential nephrotoxicity of cephalosporins.
    Mondorf AW; Scherberich JE; Heinert G; Schoeppe W
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():251-4. PubMed ID: 6137472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue.
    Yanagida C; Ito K; Komiya I; Horie T
    Chem Biol Interact; 2004 Jul; 148(3):139-47. PubMed ID: 15276870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Side effects of aminoglycosides: nephrotoxicity (author's transl)].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Infection; 1976; 4(4):231-8. PubMed ID: 65328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats.
    Konishi H; Morita Y; Mizumura M; Iga I; Nagai K
    J Chemother; 2013 Oct; 25(5):273-8. PubMed ID: 24070134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.